Genomic Predictors of Outcome in Prostate Cancer
Peter J. Boström1, Anders S. Bjartell2, James W.F. Catto3, Scott E. Eggener4, Hans Lilja5,6,7, Stacy Loeb8, Jack Schalken9, Thorsten Schlomm10, Matthew R. Cooperberg11
1Department of Urology, Turku University Hospital, Turku, Finland
2Department of Urology, Skåne University Hospital Malmö, Lund University, Lund Sweden
3Academic Urology Unit, University of Sheffield, Sheffield, UK
4Section of Urology, University of Chicago, Chicago, IL, USA
5Departments of Laboratory Medicine, Surgery (Urology), and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
7Institute of Biomedical Technology, University of Tampere, Tampere, Finland
8Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, NY, USA
9Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
10Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11Departments of Urology and Epidemiology and Biostatistics, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Urology
Tập 68
1033-1044
Thông tin tác giả